Kit For The Preparation Of Lymphoseek (technetium Tc 99m Tilmanocept) Kit
Product Images NDC 65857-425

5 FDA label images from Cardinal Health 414, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Kit For The Preparation Of Lymphoseek (technetium Tc 99m Tilmanocept) (NDC 65857-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 414, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
Illustration showing dimensions and key lines (origin, mid, solvent front) on Whatman Grade 1, 3MM, 31ET Chromatography strip and Biodex 150-001 Red Strips, indicating distances in centimeters for chromatographic analysis.*
FDA Label Image

Structural Formula (Image 02)

Structural Formula (Image 02)
Chemical structure diagram depicting the molecular composition of tilmanocept, including a technetium Tc 99m (99mTc) coordination complex. The structure shows carbohydrate rings with functional groups and the coordination site for technetium, illustrating the relationship between the chemical components in the preparation of Lymphoseek.*
FDA Label Image

Principal Display Panel (Full Carton)

Principal Display Panel (Full Carton)
Packaging label for Kit for the preparation of Lymphoseek (technetium Tc 99m tilmanocept) injection, containing 250 mcg tilmanocept per vial. The kit includes five vials of lyophilized tilmanocept powder. Label shows storage instructions, warnings, lot and expiry placeholders, and is distributed by Cardinal Health 414, LLC, Dublin, OH.*
FDA Label Image

Principal Display Panel (Image 04)

Principal Display Panel (Image 04)
Kit for the preparation of Lymphoseek (technetium Tc 99m tilmanocept) injection, containing 250 mcg tilmanocept per vial. The label shows contents including five vials of tilmanocept powder, prescribing information, radioassay shield labels, and product labels. It includes storage conditions and company information from Cardinal Health 414, LLC.*
FDA Label Image

Principal Display Panel (Diluent Label)

Principal Display Panel (Diluent Label)
Label for the diluent of Lymphoseek, a kit containing 4.5 mL of a non-pyrogenic aqueous solution with potassium phosphate, sodium phosphate (heptahydrate), sodium chloride, and phenol. The label states it is for diluting radiolabeled Lymphoseek only, not for direct administration. Distributed by Cardinal Health 414, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.